Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

712
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
712
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.4K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.4K
Viral Mutations00:36

Viral Mutations

39.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.6K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

768
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
768
Pneumonia IV: Management01:28

Pneumonia IV: Management

740
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
740

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Emerging Piperazine Derivatives: Synthesis, Characterization, Biological Evaluation, Molecular Docking, and ADMET In silico Studies.

Drug metabolism and bioanalysis·2026
Same author

From gastric to neuroprotection: pantoprazole mitigates epilepsy via TrkB/BDNF and KCC2 modulation.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

A Review on the Pathophysiology of Alzheimer's Disease.

Current protein & peptide science·2025
Same author

Pathological Insights into Neurodegenerative and Neurodevelopmental Disorders: Perspectives for the Development of Novel Treatment Approaches.

CNS & neurological disorders drug targets·2025
Same author

Molecular mechanisms and emerging therapeutics in pulmonary fibrosis: A recent update.

European journal of pharmacology·2025
Same author

Bruton's Tyrosine Kinase Inhibitors: A Versatile Therapeutic Approach for Cancer, Autoimmune Disorders, GVHD and COVID-19.

Mini reviews in medicinal chemistry·2025

相关实验视频

Updated: Jan 11, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.3K

人类甲型肺炎病毒的综合性审查

Uma Agarwal1, Swati Paliwal1, Rajiv Kumar Tonk1

  • 1Department of Pharmaceutical Chemistry, Delhi Pharmaceutical Sciences & Research University, Delhi, 110017, India.

Current gene therapy
|November 9, 2025
PubMed
概括

人类甲型肺炎病毒 (HMPV) 引起呼吸系统疾病,但不如HRSV严重,并且没有季节性趋势. 副感染和损伤风险需要进一步研究.

科学领域:

  • 病毒学 病毒学
  • 公共卫生 公共卫生
  • 传染性疾病 传染性疾病

背景情况:

  • 人类甲肺病毒 (HMPV) 是一种具有类似感冒症状的呼吸道病毒,通过水滴和表面传播.
  • 它对弱势群体,特别是幼儿构成重大威胁,并导致婴儿死亡率.
  • 2001年首次发现HMPV,这突显了对其影响的持续研究.

研究的目的:

  • 巩固关于人类甲肺病毒 (HMPV) 和它对呼吸系统疾病的影响的重要信息.
  • 推进对HMPV相关疾病的了解,并为公共卫生应对提供信息.
  • 识别知识差距,指导未来对HMPV的研究和干预.

主要方法:

  • 通过使用主要数据库进行了全面的文献搜索,截至2025年5月.
  • 研究的选择是基于对全球人类甲型肺炎病毒的广泛先前研究.
  • 该审查综合了有关HMPV流行病学,临床特征和结果的现有数据.

主要成果:

  • HMPV呈现逐渐的突变,导致临床表现中适度变化的新菌株.
  • 与其他呼吸道病毒不同,HMPV没有显著的季节性发病率模式.
  • 虽然HMPV感染的严重程度通常低于HRSV,但儿童的同时感染会增加急性损伤 (AKI) 的严重程度和风险.
关键词:
人类甲型肺炎病毒传染性疾病.传染性疾病.呼吸道感染 呼吸道感染呼吸道病毒的病毒疫苗研发疫苗的发展.

更多相关视频

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.4K
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

12.4K

相关实验视频

Last Updated: Jan 11, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.3K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.4K
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

12.4K

结论:

  • HMPV的进化轨迹限制了流行病的可能性,但同时感染和AKI风险需要监测和研究.
  • 以前存在的免疫力可能会减轻HMPV的影响,这表明疫苗或免疫增强策略的潜力.
  • 进一步的研究和常规的HMPV测试对于开发有效的治疗和预防策略至关重要,特别是在风险群体.